Lead party: Actis LLP (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Les Laboratoires MédiS (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria, Tunisia
Transaction type: Investment, Exit · Asset class: Private Equity · Strategy: Secondary Sale · Instrument: Equity
Lead investor/buyer: Actis LLP · Investors/buyers: Actis LLP · Sellers: AfricInvest Capital Partners LLC
Legal advisers: not identified in the source record.
Source: announced 2 September 2016. Original announcement: act.is.


